Corient Private Wealth
NUVB icon

Corient Private Wealth’s Nuvation Bio NUVB Stock Holding History

Corient Private Wealth’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.47M Buy
434,873
+90,710
+26% +$443K ﹤0.01% 1260
2026
Q1 		$1.48M Buy
344,163
+90,060
+35% +$502K ﹤0.01% 1423
2025
Q4 		$2.28M Buy
+254,103
New +$1.57M ﹤0.01% 1081
2023
Q3 		– Sell
-16,420
Closed -$29.6K – 2207
2023
Q2 		$29.6K Buy
+16,420
New +$27.9K ﹤0.01% 2038

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Corient Private Wealth's NUVB Position: Q2 2026 in Review

Corient Private Wealth increased its Nuvation Bio (NUVB) stake by 26% in Q2 2026, buying an estimated $443K and bringing the position to 434,873 shares worth $2.47M. The position accounts for ﹤0.01% of the portfolio, ranked #1260.

Corient Private Wealth first reported a position in NUVB in Q2 2023 and has held it in 4 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Corient Private Wealth held 434,873 shares of Nuvation Bio worth $2.47M as of Q2 2026.
  • Corient Private Wealth bought 90,710 Nuvation Bio shares in Q2 2026, an estimated $443K.
  • Nuvation Bio made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1260 holding.
  • Corient Private Wealth first reported a position in Nuvation Bio in Q2 2023 and has held it in 4 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.